Barnaby Pickering

London

Reporter at Medtech Insight

Featured in: Favicon

informa.com (+3) Favicon

citeline.com (+1)

Articles

Diagnostics Are Essential, But How Can Companies Ensure A Fair Price?

2 weeks ago | insights.citeline.com | Barnaby Pickering

Diagnostics Are Essential, But How Can Companies Ensure A Fair Price? Biotech and pharma are increasingly clear about one thing: They need diagnostics. But with prices suppressed, how have diagnostics companies proven their utility without going under?
As The Dust Settles, What Can We Learn From The J&J Vs. Auris Case?

2 months ago | insights.citeline.com | Barnaby Pickering

As The Dust Settles, What Can We Learn From The J&J Vs. Auris Case? 04 Feb 2025 • By Barnaby PickeringIn September last year, J&J lost a court case surrounding its 2019 purchase of Auris health, and was ordered to pay over $1bn in damages. Reactions to the potentially precedent-setting news were harsh and quick. In Vivo spoke to legal, M&A and BD experts from across the medtech industry to learn more about the true impacts.
Genetic Analysis Leaders On Gut Microbiota Testing, Pharma Connections And Direct-To-Consumer Scene

Jan 17, 2025 | insights.citeline.com | Barnaby Pickering

Genetic Analysis Leaders On Gut Microbiota Testing, Pharma Connections And Direct-To-Consumer SceneGenetic Analysis CEO Ronny Hermansen and Christina Casén, senior VP of clinical and medical affairs, discuss the company’s polymerase chain reaction (PCR)-based approach to gut microbiota profiling versus DNA sequencing, competitive landscape, and opportunities for supporting pharma R&D and assessing drug treatment success.
When It Comes To Spine, Incumbents Are ‘Not Listening To Surgeons,’ Says Spineart CEO Jerome Trividic

Jan 2, 2025 | insights.citeline.com | Barnaby Pickering

When It Comes To Spine, Incumbents Are ‘Not Listening To Surgeons,’ Says Spineart CEO Jerome TrividicJerome Trividic, CEO of Swiss company Spineart, believes that by solving pain points felt by orthopedic surgeons performing spinal procedures, it can improve patient outcomes. He thinks the firm’s innovative approach, which focuses on partnership deals as well as developing its own products, will give it a competitive edge in the spinal surgery market.
La French Touch: How France Has Built a Reputation for Excellence In Medtech

Jan 1, 2025 | insights.citeline.com | Barnaby Pickering

La French Touch: How France Has Built a Reputation for Excellence In MedtechFrance’s medtech sector is strong, growing and innovative. In Vivo spoke to several French medtech leaders about the unique features and pitfalls their industry may face.
Device-Activated Drugs, An Old Dog With Some New Tricks

Dec 18, 2024 | insights.citeline.com | Barnaby Pickering

Device-Activated Drugs, An Old Dog With Some New TricksAs technologies move from the lab to commercialization, changes to them need to be made to make them financially and practically appropriate for clinical settings. In Vivo spoke to two companies pioneering new types of device-activated drugs to learn about these changes and how the end products will help patients.
New Manufacturing Technologies Are Here - What's Stopping Their Implementation?

Nov 17, 2024 | insights.citeline.com | Barnaby Pickering

New Manufacturing Technologies Are Here – What's Stopping Their Implementation? Pharmaceutical manufacturing is developing at a lightning pace as the confluence of automation and AI creates opportunities for much higher efficiency and throughput. Experts from across the industry discuss these, and the challenges around implementation and standardization.
La French Touch: How France Has Built a Reputation for Excellence In Medtech

Nov 13, 2024 | insights.citeline.com | Barnaby Pickering

La French Touch: How France Has Built a Reputation for Excellence In MedtechFrance’s medtech sector is strong, growing and innovative. Medtech Insight spoke to several French medtech leaders about the unique features and pitfalls their industry may face. French Flag (Shutterstock)
GlucoModicum’s Magnetohydrodynamic CGM Platform Moves Closer To The Clinic

Nov 6, 2024 | insights.citeline.com | Barnaby Pickering

GlucoModicum’s Magnetohydrodynamic CGM Platform Moves Closer To The Clinic06 Nov 2024 • By Barnaby PickeringThe company has taken the ambitious approach of establishing a manufacturing base capable of producing millions of devices before any attempt at a regulatory submission.
Guardant’s CMO On Future Of Liquid Biopsy, CDx, And Next Directions For Shield Test

Oct 28, 2024 | insights.citeline.com | Barnaby Pickering

Guardant’s CMO On Future Of Liquid Biopsy, CDx, And Next Directions For Shield Test28 Oct 2024 • By Barnaby PickeringCraig Eagle, chief medical officer of Guardant Health, provides his view on an increasingly competitive liquid biopsy market in this interview with Medtech Insight.